Incidence of very rare thromboembolic events was far lower than in people diagnosed with COVID-19 infection

Attachments

  • Original document
  • Permalink

Disclaimer

AstraZeneca plc published this content on 28 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 July 2021 06:12:03 UTC.